How to Build the Ultimate V-Taper
Exercises for a Wide Back, Broad Shoulders and Small Waist
What is the most glaring visual signal that identifies a bodybuilder to a distant observer? You could say it’s simply the sheer size and thickness of his or her muscles relative to the average man, but from far away it’s nearly impossible to distinguish between muscular bulk and just plain fat. Bodybuilders have a specific shape that marks them as part of an elite group, and that shape is what’s known as a “V-Taper.” The phrase derives its origin from the inverted pyramid form of the letter V itself; wide on top and narrowing to a tiny point. On a human body, this translates into wide lats and shoulders tapering down to a small waist. It’s a look that’s highly sought after, and with good reason. Many of the most aesthetically stunning bodybuilders of all time have had exaggerated V-tapers: Sergio Oliva,
Black History Month: 15 Legendary African American Bodybuilders bodybuilding.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bodybuilding.com Daily Mail and Mail on Sunday newspapers.
By Steve Blechman
A new study published, November 23, 2020, in the journal Cell Metabolism found that giving insulin to type 2 diabetics infected with the coronavirus increased mortality and death. According to the researchers, “COVID-19 caused by SARS-CoV-2 infection can lead to multi-organ injuries and significant mortality in severe and critical patients, especially among those individuals with type 2 diabetes (T2D) as a comorbidity. While attenuated mortality was observed with aggressive glucose control, it was unclear whether therapeutic regimens including insulin treatment were beneficial for patients with COVID-19 and T2D. This retrospective study investigated 689 patients with COVID-19 and T2D from a cohort of 3,305 cases from Wuhan, China. Unexpectedly, we found that insulin treatment for patients with COVID-19 and T2D was associated with a significant increase in mortality (27.2% versus 3.5%; adjusted HR, 5.38 [2.75-10.54]). Further analysis showed that insulin tre